| Medical and Health Sciences | 2021-2025 | 241 | PL 3 | 99.95 |
| Dermatology | Lifetime | 28 | PL 1 | 99.78 |
| Immunology | Lifetime | 769 | PL 2 | 97.52 |
| Rheumatology | Lifetime | 638 | PL 2 | 96.84 |
| Immunology and Allergy | Lifetime | 371 | PL 1 | 94.20 |
| Urology | Lifetime | 765 | PL 6 | 76.50 |
| Dermatology | 2021-2025 | 6 | PL 1 | 99.92 |
| Immunology | 2021-2025 | 137 | PL 2 | 97.15 |
| Epidemiology | 2021-2025 | 347 | PL 2 | 97.23 |
| Surgery | 2021-2025 | 465 | PL 2 | 96.32 |
| Urology | 2021-2025 | 76 | PL 2 | 92.51 |
| Immunology and Allergy | 2021-2025 | 104 | PL 1 | 91.67 |
| Rheumatology | 2021-2025 | 305 | PL 2 | 89.39 |
| Clinical Psychology | 2021-2025 | 881 | PL 8 | 90.10 |
| Medical Physiology | 2021-2025 | 786 | PL 5 | 87.09 |
| Cell Biology | 2021-2025 | 242 | PL 2 | 74.96 |
| Pathology and Forensic Medicine | 2021-2025 | 513 | PL 7 | 73.68 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 4 | PL 1 | 99.29 |
| Dermatology and Skin Diseases | Lifetime | 63 | PL 1 | 99.59 |
| Nail Diseases and Treatments | Lifetime | 37 | PL 1 | 99.44 |
| Urticaria and Related Conditions | Lifetime | 38 | PL 1 | 99.40 |
| Colorectal and Anal Carcinomas | Lifetime | 75 | PL 1 | 99.22 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 68 | PL 1 | 99.32 |
| Allergic Rhinitis and Sensitization | Lifetime | 209 | PL 3 | 99.09 |
| Autoimmune Bullous Skin Diseases | Lifetime | 143 | PL 2 | 98.65 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 128 | PL 1 | 98.46 |
| Chemotherapy-related skin toxicity | Lifetime | 56 | PL 1 | 97.34 |
| Contact Dermatitis and Allergies | Lifetime | 270 | PL 1 | 97.66 |
| Body Image and Dysmorphia Studies | Lifetime | 115 | PL 1 | 97.16 |
| Fungal Infections and Studies | Lifetime | 439 | PL 1 | 97.12 |
| Cancer and Skin Lesions | Lifetime | 447 | PL 4 | 96.58 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 787 | PL 3 | 96.27 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 424 | PL 2 | 96.30 |
| Food Allergy and Anaphylaxis Research | Lifetime | 533 | PL 3 | 96.63 |
| Skin Protection and Aging | Lifetime | 488 | PL 4 | 95.98 |
| Acne and Rosacea Treatments and Effects | Lifetime | 232 | PL 1 | 95.38 |
| Microscopic Colitis | Lifetime | 916 | PL 2 | 95.85 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 566 | PL 3 | 95.09 |
| Dermatological and COVID-19 studies | Lifetime | 158 | PL 1 | 91.82 |
| Infection Control and Ventilation | Lifetime | 512 | PL 5 | 91.50 |
| Autoimmune and Inflammatory Disorders | Lifetime | 753 | PL 2 | 90.20 |
| Therapeutic Uses of Natural Elements | Lifetime | 393 | PL 3 | 88.29 |
| Hair Growth and Disorders | Lifetime | 691 | PL 9 | 88.94 |
| Tattoo and Body Piercing Complications | Lifetime | 107 | PL 2 | 85.16 |
| Skin Diseases and Diabetes | Lifetime | 607 | PL 10 | 85.76 |
| Dermatological diseases and infestations | Lifetime | 943 | PL 6 | 81.32 |
| Neonatal skin health care | Lifetime | 804 | PL 3 | 53.54 |
| Colorectal and Anal Carcinomas | 2021-2025 | 6 | PL 1 | 99.47 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 2 | PL 1 | 99.48 |
| Dermatology and Skin Diseases | 2021-2025 | 21 | PL 1 | 99.67 |
| Anorectal Disease Treatments and Outcomes | 2021-2025 | 17 | PL 1 | 98.32 |
| Urticaria and Related Conditions | 2021-2025 | 30 | PL 1 | 98.52 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 62 | PL 2 | 98.65 |
| Skin Protection and Aging | 2021-2025 | 42 | PL 1 | 96.60 |
| Cancer and Skin Lesions | 2021-2025 | 30 | PL 1 | 96.18 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 98 | PL 2 | 98.38 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 58 | PL 1 | 96.46 |
| Asthma and respiratory diseases | 2021-2025 | 299 | PL 2 | 97.22 |
| Contact Dermatitis and Allergies | 2021-2025 | 57 | PL 1 | 96.06 |
| Nail Diseases and Treatments | 2021-2025 | 70 | PL 2 | 94.96 |
| Dermatologic Treatments and Research | 2021-2025 | 106 | PL 2 | 94.84 |
| Microscopic Colitis | 2021-2025 | 208 | PL 2 | 96.70 |
| Chemotherapy-related skin toxicity | 2021-2025 | 22 | PL 1 | 93.51 |
| Hair Growth and Disorders | 2021-2025 | 63 | PL 3 | 93.69 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 200 | PL 4 | 91.51 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 273 | PL 4 | 92.88 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 439 | PL 12 | 87.35 |
| Body Image and Dysmorphia Studies | 2021-2025 | 149 | PL 3 | 85.49 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 802 | PL 6 | 84.99 |
| Fungal Infections and Studies | 2021-2025 | 646 | PL 6 | 85.26 |
| Medicine and Dermatology Studies History | 2021-2025 | 65 | PL 3 | 76.41 |
| melanin and skin pigmentation | 2021-2025 | 499 | PL 9 | 77.24 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 976 | PL 10 | 76.77 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 419 | PL 16 | 73.39 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 563 | PL 8 | 68.74 |
| Genetic and rare skin diseases. | 2021-2025 | 244 | PL 6 | 66.56 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 235 | PL 5 | 65.71 |
| Reconstructive Facial Surgery Techniques | 2021-2025 | 927 | PL 12 | 65.32 |
| Transgenic Plants and Applications | 2021-2025 | 634 | PL 7 | 60.94 |
| Tattoo and Body Piercing Complications | 2021-2025 | 65 | PL 1 | 60.46 |
| Dermatological diseases and infestations | 2021-2025 | 403 | PL 7 | 59.81 |
| Skin Diseases and Diabetes | 2021-2025 | 447 | PL 12 | 53.04 |
| Dermatological and COVID-19 studies | 2021-2025 | 994 | PL 8 | 42.21 |